PIMREG and head and neck squamous cell carcinoma: For the TCGA HNSCC cohort, overall survival (OS) and disease-free survival (DFS) were both significantly worse among patients in the high FAM64A expression group than among those in the low FAM64A expression group (Fig. S1j, k).